MEDICAL DISCLAIMER AND IMPORTANT SAFETY INFORMATION

The content on this website serves educational purposes only and does not replace professional medical consultation, diagnosis, or treatment recommendations. Consult with your physician or qualified healthcare practitioner regarding any medical concerns or treatment decisions.

GLP-1 Receptor Agonist Weight Loss Medications

Our medical weight loss programs may include GLP-1 receptor agonist medications that require prescription authorization and continuous medical oversight by licensed healthcare professionals. Treatment outcomes differ substantially between individuals based on starting weight, health history, lifestyle factors, treatment adherence, and personal medication response. We cannot guarantee weight loss results, as some patients may experience limited or no weight reduction despite proper compliance.

Tirzepatide (Active Pharmaceutical Ingredient in Mounjaro®) – Complete prescribing details, contraindications, warnings, and safety precautions available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf

Semaglutide (Active Pharmaceutical Ingredient in Wegovy®) – Complete prescribing details, contraindications, warnings, and safety precautions available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf

CRITICAL SAFETY WARNINGS FOR GLP-1 MEDICATIONS:

Thyroid Tumor Risk: Animal studies revealed increased thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). Human risk remains unknown. These medications are contraindicated for individuals with personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Immediately report neck lumps, swelling, hoarseness, swallowing difficulties, or breathing problems to your provider.

Serious Adverse Effects Requiring Immediate Medical Attention:

• Acute pancreatitis symptoms: persistent severe abdominal pain, possibly radiating to back, with or without vomiting
• Gallbladder complications: upper abdominal pain, jaundice, fever, clay-colored stools
• Severe allergic reactions: facial/throat swelling, severe rash, rapid heartbeat, breathing difficulties
• Kidney injury: particularly with dehydration from gastrointestinal side effects
• Diabetic retinopathy worsening in diabetic patients
• Hypoglycemia when combined with diabetes medications
• Mental health changes including suicidal ideation
• Surgical complications due to delayed gastric emptying

Common Side Effects:

Nausea, vomiting, diarrhea, constipation, abdominal discomfort, headache, fatigue, injection site reactions.

Contraindications:

Personal or family history of MTC, MEN 2, known allergies to active ingredients, pregnancy, severe gastrointestinal disease.

Testosterone Replacement Therapy

TRT requires comprehensive medical assessment and continuous monitoring by qualified healthcare providers. Individual responses vary significantly based on baseline hormone levels, age, health status, and physiological factors.

Testosterone Cypionate (Active Pharmaceutical Ingredient in Depo®-Testosterone) – Complete prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/085635s040lbl.pdf

Anastrozole (Active Pharmaceutical Ingredient in Arimidex®) – Complete prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020541s026lbl.pdf

Clomiphene Citrate (Active Pharmaceutical Ingredient in Clomid®) – Complete prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/016131s026lbl.pdf

Women’s Hormone Replacement Therapy

HRT requires thorough medical evaluation and ongoing supervision by qualified healthcare professionals. Treatment responses vary widely based on hormonal baseline, age, health status, menopausal stage, and individual physiology.

Menopause Treatment Information: https://www.fda.gov/files/for%20consumers/published/Menopause-Medicines-To-Help-You.pdf

Estradiol Patch – Complete prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206685Orig1s000Lbl.pdf

Estradiol Tablet – Complete prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/anda/97/40197ap.pdf

Bi-Est Cream – Conjugated estrogen information: https://www.accessdata.fda.gov/drugsatfda_docs/psg/Conjugated_estrogens_004782_RC12-14.pdf

Micronized Progesterone Tablet – Complete prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019781s013lbl.pdf

Treatment Exclusions and Contraindications

Our services are not appropriate for individuals with: pregnancy or nursing status, age under 18, unstable medical conditions, active substance dependency, untreated eating disorders, psychiatric conditions affecting treatment compliance, hormone-sensitive malignancies, thrombotic disorders, severe hepatic disease, cardiovascular contraindications, or other medical exclusions specified in FDA labeling.

Mandatory Medical Supervision

All treatments require: initial comprehensive medical consultation, laboratory assessments, ongoing monitoring protocols, and regular follow-up evaluations with our healthcare providers. Patients must provide complete medical histories, current medication lists, and adhere to all prescribed safety protocols. Monitoring may include blood work, physical examinations, and adverse effect assessments.

Treatment Outcome Disclaimer

While many patients achieve desired results, we provide no guarantees regarding specific treatment outcomes. Individual medication responses vary considerably based on patient compliance, lifestyle modifications, baseline health status, and individual physiological characteristics.

Regulatory and Off-Label Use Notice

Medications in our protocols are FDA-approved prescription drugs for specific indications. Some medications may be prescribed for off-label applications as determined by our healthcare providers based on clinical judgment and current medical evidence. Treatment decisions are made exclusively by licensed healthcare professionals following comprehensive medical evaluation.

Patient Acknowledgment

By utilizing our services, you acknowledge understanding of these risks and limitations, confirm receipt of access to complete FDA prescribing information for all medications, and agree to active participation in your medical care under appropriate healthcare supervision.

For emergency situations, contact 911 or seek immediate medical attention. Report adverse effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.